✦ LIBER ✦

Docetaxel: clinical benefit in first-line treatment for NSCLC

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel first line use in advanced NSC

✍ Nicolson, M.; Bissett, D.; Armstrong, S.; Brown, L.; Remmen, H.; Devereux, G.; G 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Irinotecan plus docetaxel a first-line o

✍ Sullivan, S 📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 179 KB

Docetaxel useful in second-line treatmen

📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 209 KB

Phase II study of docetaxel and carbopla

✍ Wachters, Floris M; van Putten, John W.G; Boezen, H.Marike; Groen, Harry J.M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Epirubicin + docetaxel in first-line tre

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Weekly docetaxel as first-line therapy f

✍ Hainsworth, J.D; Burris, H.A; Morrissey, L.H; Litchy, S; Greco, F.A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 96 KB